Advertisement

Metabolic Brain Disease

, 26:253 | Cite as

Non-alcoholic fatty liver induces insulin resistance and metabolic disorders with development of brain damage and dysfunction

  • Doaa A. Ghareeb
  • Hani S. Hafez
  • Hend M. Hussien
  • Nihal F. Kabapy
Original Paper

Abstract

In the present study we investigated the effect of the non-alcoholic fatty liver disease (NAFLD) on the alterations in the activity of neurotransmitters catabolizing enzymes and energy catabolising enzymes, prooxidants, endogenous antioxidants and proinflammatory cytokines in brain tissue of NAFLD rats. Rats were intraperitonealy injected with CCl4 solution at a dose of (0.021 mole/Kg, 20 μL, body weight) three times weekly for four weeks. Acetylcholine esterase (AChE), monoamine oxidase (MAO), prooxidant/ antioxidants status, ATPase, lipid profile and glucose level were estimated spectrophotometrically while inflammatory markers; interleukin 6 and tumor necrosis factor alpha (IL6 and TNF-α) and insulin were assessed by ELISA technique. Our results showed that the induced NAFLD and insulin resistance (IR) were accompanied with hyperglycemia and hyperlipidemia and lowered brain glucose level with elevated ATPase activity, prooxidant status (TBARS level, xanthine oxidase and cytochrome 2E1 activities), and inflammatory markers. Through the induction period AChE activity was significantly increased compared to control in blood, liver and brain tissues. Also, MAO activity was significantly increased in both brain and liver tissue but decreased in serum compared with control. These biochemical data were supported with pathophysiological analysis that showed severe neurodegeneration, pyknosis acuolations and cavitations. These observations warrant the reassessment of the conventional concept that the NAFLD with IR progression may induce disturbances in activities of neurotransmitters catabolising enzymes and energy production accompanied with oxidative stress and metabolic disorders, acting as relative risk factors for brain dysfunction and damage with the development of age-associated neurodegenerative diseases such as Alzheimer's disease.

Keywords

NAFLD Insulin resistance Brain dysfunction AChE MAO 

Notes

Acknowledgements

Special thanks for Prof Dr. Ashraf A. Khalil, protein technology department, the city of scientific research and Application technology, who gave us several advises through the work design.

Competing interests

There is neither financial competing interest (political, personal, religious, ideological, academic, intellectual, commercial or any other) to declare in relation to this manuscript.

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. Ahboucha S, Butterworth R (2008) The neurosteriod system: implication in the pathophysiology of hepatic eccephalopathy. Neurochem Int 52:575–585PubMedCrossRefGoogle Scholar
  2. Aleynik S, Leo M, Aleynik M, Leiber C (1997) Polyenyphosphatidylcholine prevents carbon tetrachloride induced lipid peroxidation while it attenuates liver fibrosis. J Hepatol 27:554–556PubMedCrossRefGoogle Scholar
  3. Anania FA, Parekh S (2007) Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease. Gastroenterology 132:2191–2207PubMedCrossRefGoogle Scholar
  4. Angelini N, Rafacho A, Boschero AC, Bosqueiro JR (2010) Involvement of the cholinergic pathway in glucocorticoid-induced hyperinsulinemia in rats. Diabetes Res Clin Pract 87:184–191PubMedCrossRefGoogle Scholar
  5. Angulo P (2007) GI epidemiology: nonalcoholic fatty liver disease: incidence and prevalence. Aliment Pharmacol Ther 25(8):883–889PubMedCrossRefGoogle Scholar
  6. Banks WA (2004) The source of cerebral insulin. Eur J Pharmacol 490:5–12PubMedCrossRefGoogle Scholar
  7. Bardov VG, Shmuter GM, Suchkov BP, Stepanenko GA, Khalavchuk IV, Gerashchenko SK, Kapelist VA (1990) The effect of a complex of preventive agents on the level of radioactive cesium and strontium in the bodies of laboratory animals (white rats). Gig Sanit 10:51–52PubMedGoogle Scholar
  8. Baura GD, Foster DM, Kaiyala K, Porte D, Kahn E, Schwartz W (1996) Insulin transport from plasma into the central nervous system is inhibited by dexamethasone in dogs. Diabetes 45(1):86–90PubMedCrossRefGoogle Scholar
  9. Beal M (2005) Mitochondria take centre stage in aging and neurodegeneration. Ann Neurol 58:495–505PubMedCrossRefGoogle Scholar
  10. Biessels GJ, Kappalle LJ (2005) Uhrecht Diabetic Encephalopathy Study Group: Increased risk of Alzheimer’s disease in Type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology? Biochem Soc Trans 33:1041–1044PubMedCrossRefGoogle Scholar
  11. Bingham E, Hopkins D, Smith D, Pernet A, Hallett W, Reed L (2002) The role of insulin in human brain glucose metabolism: an fluoro-deoxyglucose positron emission tomography study. Diabetes 51(12):3384–3390PubMedCrossRefGoogle Scholar
  12. Bosetti F, Brizzi F, Barogia S, Mancuso M, Siciliano G, Tendi E, Murric L, Rapoport S, Solaini G (2002) Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer’s disease. Neurobiol Aging 23:371–376PubMedCrossRefGoogle Scholar
  13. Browning JD, Horton JD (2004) Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 114:147–152PubMedGoogle Scholar
  14. Cai D, Yuan M, Frantz DF et al (2005) Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med 11:183–190PubMedCrossRefGoogle Scholar
  15. Calabrese V, Scapagnini G, Giuffrida-Stella A, Bates T, Clark J (2001) Mitochondrial involvement in brain function and dysfunction: relevance to aging, neurodegenerative disorders and longevity. Neurochem Res 26:739–764PubMedCrossRefGoogle Scholar
  16. Candeiasa F, Abreub P, Pereiraa A, Cruz-Morais J (2009) Effects of strictosamide on mouse brain and kidney Na+, K+−ATPase and Mg2+−ATPase activities. J Ethnopharmacology 121:117–122CrossRefGoogle Scholar
  17. Cao Q, Mak KM, Lieber CS (2005) Cytochrome P4502E1 primes macrophages to increase TNF-_ production in response to lipopolysaccharide. Am J Physiol Gastrointest Liver Physiol 289:G95–G107PubMedCrossRefGoogle Scholar
  18. Caro A, Evans L, Cederbaum I (2009) CYP2E1 overexpression inhibits microsomal Ca2+−ATPase activity in HepG2 cells. Toxicology 255:171–176PubMedCrossRefGoogle Scholar
  19. Chavez JA, Summers SA (2003) Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes. Arch Biochem Biophys 419:101–109PubMedCrossRefGoogle Scholar
  20. Choudhary P, Malik V, Puri S, Ahluwalia P (1996) Studies on the effects of monosodium glutamate on hepatic microsomal lipid peroxidation, calcium, ascorbic acid and glutathione and its dependent enzymes in adult male mice. Toxicol Lett 89:71–76PubMedCrossRefGoogle Scholar
  21. Cibickova L, Hyspler R, Micuda S, Cibicek N, Jun D, Ticha A, Brcakova E, Palicka V, Zivna H (2009) The influence of simvastatin, atorvastatin and high-cholesterol diet on acetylcholinesterase activity, amyloid beta and cholesterol synthesis in rat brain. Steroids 74:13–19PubMedCrossRefGoogle Scholar
  22. Craft S (2005) Insulin resistance syndrome and Alzheimer’s disease: age- and obesity-related effects on memory, amyloid, and inflammation. Neurobiol Aging 26:65–69PubMedCrossRefGoogle Scholar
  23. Craft S, Watson G (2004) Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol 3(3):169–178PubMedCrossRefGoogle Scholar
  24. Craft S, Asthana S, Newcomer JW, Wilkinson CW, Matos IT, Baker LD et al (1999) Enhancement of memory in Alzheimer’s disease with insulin and somatostatin, but not glucose. Arch Gen Psychiatry 56:1135–1140PubMedCrossRefGoogle Scholar
  25. Day CP, James OF (1998) Steatohepatitis: a tale of two “hits”? Gastroenterology 114:842–845PubMedCrossRefGoogle Scholar
  26. De Luis DA, Aller R, Izaola O et al (2008) Effect of a hypocaloric diet in transaminases in nonalcoholic fatty liver disease and obese patients, relation with insulin resistance. Diabetes Res Clin Pract 79:74–78PubMedCrossRefGoogle Scholar
  27. Diehl AM (2002) Nonalcoholic steatosis and steatohepatitis IV. Nonalcoholic fatty liver disease abnormalities in macrophage function and cytokines. Am J Physiol Gastrointest Liver Physiol 282:G1–G5PubMedGoogle Scholar
  28. Drake H, Goss H, Wood G (1979) New convenient method for the rapid analysis of inorganic pyrophosphate. Anal Biochem 94:117–120PubMedCrossRefGoogle Scholar
  29. Eckel RH, Grundy SM, Zimmet PZ (2005) The metabolic syndrome. Lancet 365:1415–1428PubMedCrossRefGoogle Scholar
  30. Ellman G, Courtney K, Andres V, Featherstone R (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88–95PubMedCrossRefGoogle Scholar
  31. Emery MG, Fisher JM, Chien JY et al (2003) CYP2E1 activity before and after weight loss in morbidly obese subjects with nonalcoholic fatty liver disease. Hepatology 38:428–435PubMedCrossRefGoogle Scholar
  32. Farrell GC, Larter CZ (2006) Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43:S99–S112PubMedCrossRefGoogle Scholar
  33. Fossati P, Prencipe L (1982) Triglyceride determination calorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 28:2077–2080PubMedGoogle Scholar
  34. Fowler J, Volkow N, Wang G, Pappas N, Logan J, Mac Gregor R, Alexoff D, Wolf A, Warner D, Cilento R, Zezulkova I (1998) Neuropharmacological action of cigarette smoke: brain monoamine oxidase B (MAOB) inhibition. J Addict Dis 17:23–34PubMedCrossRefGoogle Scholar
  35. Ghareeb D, Hussein H (2008) Vanadium improves brain acetylcholinesterase activity on early stage alloxan-diabetic rats. Neurosci Lett 436:44–47PubMedCrossRefGoogle Scholar
  36. Ghareeb D, Hussein H, Khalil A, El-Saadani M, Ali A (2010a) Toxic effects of lead exposure on the brain of rats: Involvement of oxidative stress, inflammation, acetylcholinesterase, and the beneficial role of flaxseed extract. Toxicol Environ Chem 92(1):187–195CrossRefGoogle Scholar
  37. Ghareeb D, Khalil A, Elbassoumy A, Hussien H, Abo-Sraiaa M (2010b) Ameliorated effects of garlic (Allium sativum) on biomarkers of subchronic acrylamide hepatotoxicity and brain toxicity in rats. Toxicol Environ Chem 92(7):1357–1372Google Scholar
  38. Halliwell B, Gutteridge J (2000) Free radicals in biology and medicine. In: (ed) Oxford University Press, pp 148–149Google Scholar
  39. Hare M (1928) Tyramine oxidase. I. A new enzyme system in liver. Biochem J 22(4):968–979PubMedGoogle Scholar
  40. Hattori N, Kitagawa K, Higashida K, Yagyu K, Shimoham S, Watay T, Perry G, Smith M, Inagaki C (1998) Cl-ATPase and Na/K-ATPase activities in Alzheimer’s disease brains. Neurosci Lett 254:141–144PubMedCrossRefGoogle Scholar
  41. Hjelm M, De Verdier C (1963) Determination of serum glucose by glucose oxidase method. Scand J Clin Lab Invest 15:415–428PubMedCrossRefGoogle Scholar
  42. Hsu C, Guo L (2002) Antioxidant nutrients and lead toxicity. Toxicology 180(1):33–44PubMedCrossRefGoogle Scholar
  43. Hu W, Gray NW, Brimijoin S (2003) Amyloid-beta increases acetylcholinesterase expression in neuroblastoma cells by reducing enzyme degradation. J Neurochem 86:470–478PubMedCrossRefGoogle Scholar
  44. Hummel S, Fischer A, Martin S, Schafer F, Buettner G (2006) Nitric oxide as a cellular antioxidant: a little goes a long way. Free Radic Biol Med 40:501–506PubMedCrossRefGoogle Scholar
  45. Hwang JH, Stein DT, Barzilai N, Cui MH, Tonelli J, Kishore P, Hawkins M (2007) Increased intrahepatic triglyceride is associated with peripheral insulin resistance: in vivo MR imaging and spectroscopy studies. Am J Physiol Endocrinol Metab 293:E1663–E1669PubMedCrossRefGoogle Scholar
  46. Institute of Laboratory Animal Resources (1996) Guide for the care and use of laboratory animals. Commission on life sciences, national research council. National Academy, Washington, DCGoogle Scholar
  47. Johansen M, Bak L, Schousboe A, Iversen P, Keiding S, Sorensen M, Vilstrup H, Gjedde A, Ott P, Waagepetersen H (2007) The metabolic role of isoleucine in detoxification of ammonia in cultured mouse neurons and astrocytes. Neurochem Int 50:1042–1051PubMedCrossRefGoogle Scholar
  48. Jollow D, Mitchell J, Zampaglione N, Gillette J (1974) Bromobenze induced liver necrosis: protective role of glutathione and evidence for 3, 4-bromobenzenoxide as the hepatotoxic intermediate. Pharmacology 11:151–169PubMedCrossRefGoogle Scholar
  49. Korenblat KM, Fabbrini E, Mohammed BS, Klein S (2008) Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects. Gastroenterology 134:1369–1375PubMedCrossRefGoogle Scholar
  50. Lam H, Yeh C, Cheng K, Hus C, Cheng J (2008) Effect of cholinergic denervation on hepatic fibrosis induced by carbon tetrachloride in rats. Neuroscience Lett 438:90–95CrossRefGoogle Scholar
  51. Litwack G, Bothwell JW, Williams JN, Elvehjem J (1953) A colorimetric assay for xanthine oxidase in rat liver homogenates. J Biol Chem 200:303–310PubMedGoogle Scholar
  52. Macdonald GA, Bridle KR, Ward PJ et al (2001) Lipid peroxidation in hepatic steatosis is associated with hepatic fibrosis and occurs predominantly in acinar zone 3. J Gastroenterol Hepatol 16:599–606PubMedCrossRefGoogle Scholar
  53. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, Natale S, Vanni E, Villanova N, Melchionda N, Rizzetto M (2003) Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 37:917–923PubMedCrossRefGoogle Scholar
  54. McCullough AJ (2004) The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. Clin Liver Dis 8:VIII521–VIII533CrossRefGoogle Scholar
  55. McGarry JD (2002) Dys-regulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51:7–18PubMedCrossRefGoogle Scholar
  56. McGarry JD, Dobbins RL (1999) Fatty acids, lipotoxicity and insulin secretion. Diabetologia 42:128–138PubMedCrossRefGoogle Scholar
  57. Meyer JH, Ginovart N, Boovariwala A, Sagrati S, Hussey D, Garcia A, Young T, Praschak-Rieder N, Wilson AA, Houle S (2006) Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression. Arch Gen Psychiatry 63(11):1209–1216PubMedCrossRefGoogle Scholar
  58. Montgomery H, Dymock J (1961) The determination of nitrite in water. Analyst 35:414–416Google Scholar
  59. Musso G, Gambino R, Cassader M (2009) Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). Prog Lipid Res 48:1–26PubMedCrossRefGoogle Scholar
  60. Neuschwander-Tetri BA, Brunt EM, Wehmeier KR et al (2003) Interim results of a pilot study demonstrating the early effects of the PPAR-g ligand rosiglitazone on insulin sensitivity, aminotransferases, hepatic steatosis and body weight in patients with non-alcoholic steatohepatitis. J Hepatol 38:434–440PubMedCrossRefGoogle Scholar
  61. Ott A, Stolk RP, Hofman A, van Harskamp F, Grobbee DE, Breteler MM (1999) Association of diabetes mellitus and dementia: The Rotterdam study. Diabetologia 39:1392–1397CrossRefGoogle Scholar
  62. Paglia E, Valentine N (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70:158–169PubMedGoogle Scholar
  63. Perez-Carreras M, Del Hoyo P, Martin MA et al (2003) Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology 38:999–1007PubMedGoogle Scholar
  64. Pessayre D, Mansouri A, Fromenty B (2002) Nonalcoholic steatosis and steatohepatitis: mitochondrial dysfunction in steatohepatitis. Am J Physiol Gastrointest Liver Physiol 282:G193–G199PubMedGoogle Scholar
  65. Petersen KF, Dufour S, Befroy D, Lehrke M, Hendler RE, Shulman GI (2005) Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes 54:603–608PubMedCrossRefGoogle Scholar
  66. Plomgaard P, Bouzakri K, Krogh-Madsen R et al (2005) Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation. Diabetes 54:2939–2945PubMedCrossRefGoogle Scholar
  67. Plummer D (1978) Amino acids and proteins. In: (ed) An introduction to practical biochemistry. UK, McGraw- Hill Book Co, pp 145–146Google Scholar
  68. Reddy JK (2001) Nonalcoholic steatosis and steatohepatitis: peroxisomal β-oxidation, PPAR-α and steatohepatitis. Am J Physiol Gastrointest Liver Physiol 281:G1333–G1339PubMedGoogle Scholar
  69. Reger MA, Watson GS, Green PS, Wilkinson CW, Baker LD, Cholerton B et al (2008) Intranasal insulin improves cognition and modulates β-amyloid in early AD. Neurology 70(6):440–448PubMedCrossRefGoogle Scholar
  70. Robertson GR, Leclercq I, Farrell GC (2001) Nonalcoholic steatosis and steatohepatitis: cytochrome P-450 enzymes and oxidative stress. Am J Physiol Gastrointest Liver Physiol 281:G1135–G1139PubMedGoogle Scholar
  71. Robin M, Sauvage I, Grandperret T, Descatoire V, Pessayre D, Fromenty B (2005) Ethanol increases mitochondrial cytochrome P450 2E1 in mouse liver and rat hepatocytes. FESB Lett 579:6895–6902CrossRefGoogle Scholar
  72. Rojo L, Sjöberg MK, Hernández P, Zambrano C, Maccioni RB (2006) Roles of cholesterol and lipids in the etiopathogenesis of Alzheimer’s disease. J Biomed Biotechnol 3:73–90Google Scholar
  73. Samuel VT, Liu ZX, Qu X, Elder BD, Bilz S, Befroy D, Romanelli AJ, Shulman GI (2004) Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J Biol Chem 279:32345–32353PubMedCrossRefGoogle Scholar
  74. Samuel VT, Liu ZX, Wang A, Beddow SA, Geisler JG, Kahn M, Zhang XM, Monia BP, Bhanot S, Shulman GI (2007) Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease. J Clin Invest 117:739–745PubMedCrossRefGoogle Scholar
  75. Sandler M, Reveley M, Glover V (1981) Human platelet monoamine oxidase activity in health and disease: a review. J Clin Pathol 34:292–302PubMedCrossRefGoogle Scholar
  76. Sanyal AJ, Campbell-Sargent C, Mirshahi F et al (2001) Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 120:1183–1192PubMedCrossRefGoogle Scholar
  77. Schildkraut JJ, Herzog JM, Orsulak PJ, Edelman SE, Shein HM, Frazier SHSH (1976) Reduced platelet monoamine oxidase activity in a subgroup of schizophrenic patients. Am J Psychiatry 133(4):438–440PubMedGoogle Scholar
  78. Seki S, Kitada T, Yamada T, Sakagushi H, Nakatani K, Wakasa K (2002) In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases. J Hepatol 37:56–62PubMedCrossRefGoogle Scholar
  79. Serviddio G, Sastre J, Bellanti F, Vina J, Vendemiale G, Altomare E (2008) Mitochondrial involvement in non-alcoholic steatohepatitis. Mol Aspects Med 29:22–35PubMedCrossRefGoogle Scholar
  80. Shoelson SE, Lee J, Goldfine AB (2006) Inflammation and insulin resistance. J Clin Invest 116:1793–1801PubMedCrossRefGoogle Scholar
  81. Srivastava L, Das N, Sinha S (2002) Quantitative estimation of analytes in blood. In: Srivastava L, Das N, Sinha S (eds) Essential of practical biochemistry. CBS publishers and distributors, New Delhi, pp 91–94Google Scholar
  82. Tokushige K, Takakura M, Tsuchiya-Matsushita N et al (2007) Influence of TNF gene polymorphisms in Japanese patients with NASH and simple steatosis. J Hepatol 46:1104–1110PubMedCrossRefGoogle Scholar
  83. Valenti L, Fracanzani AL, Dongiovanni P et al (2002) Tumor necrosis factor-alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease. Gastroenterology 122:274–280PubMedCrossRefGoogle Scholar
  84. Videla LA, Rodrigo R, Orellana M et al (2004) Oxidative stress-related parameters in the liver of nonalcoholic fatty liver disease patients. Clin Sci 106:261–268PubMedCrossRefGoogle Scholar
  85. Vives-Bauza C, Gonzalo R, Manfredi G, Garcia-Arumi E, Andreu A (2006) Enhanced ROS production and antioxidant defenses in cybrids harbouring mutations in mtDNA. Neurosci Lett 391:136–141PubMedCrossRefGoogle Scholar
  86. Watson D (1960) A simple method for the determination of serum cholesterol. Clinica Chemica Acta 5:637–643CrossRefGoogle Scholar
  87. Watson GS, Craft S (2006) Insulin resistance, inflammation, and cognition in Alzheimer’s Disease:Lessons for multiple sclerosis. J Neurol Sci 245:21–33PubMedCrossRefGoogle Scholar
  88. Weber L, Boll M, Stampfl A (2003) Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Crit Rev Toxicol 33:105–136PubMedCrossRefGoogle Scholar
  89. Weltman MD, Farrell GC, Hall P, Ingelman-Sundberg M, Liddle C (1998) Hepatic cytochrome P450 2E1 is increased in patients with non alcoholic steatohepatitis. Hepatology 28:128–133CrossRefGoogle Scholar
  90. Wills ED (1965) Mechanisms of lipid peroxide formation in animal tissues. Biochem J 99(3):667–676Google Scholar
  91. Yu C, Wang F, Jin C, Wu X, Chan W, McKeehan W (2002) Increased carbon tetrachloride-induced liver injury and fibrosis in FGFR4-deficient mice. Am J Pathol 161:2003–2010PubMedCrossRefGoogle Scholar
  92. Zhao WQ, Alkon DL (2001) Role of insulin and insulin receptor in learning and memory. Mol Cell Endocrinol 177(1–2):125–134PubMedCrossRefGoogle Scholar
  93. Zheng S, Newton GL, Gonick G, Fahey RC, Ward JF (1988) Radioprotection of DNA by thiols: relationship between the net charge on a thiol and its ability to protect DNA. Radiat Res 114:11–27PubMedCrossRefGoogle Scholar
  94. Zollner N, Kirsch K (1962) Absorptimetric determination of total lipids in serum. Z Ges Exp Med 135:544–549CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Doaa A. Ghareeb
    • 1
  • Hani S. Hafez
    • 2
    • 5
  • Hend M. Hussien
    • 3
  • Nihal F. Kabapy
    • 4
  1. 1.Department of Biochemistry, Faculty of ScienceAlexandria UniversityAlexandriaEgypt
  2. 2.Faculty of Science and Art, Department of BiologyKing Khaled UniversityBeshaSaudi Arabia
  3. 3.Faculty of Pharmacy and drug manufacturingPharos UniversityAlexandriaEgypt
  4. 4.Faculty of PharmacyAlexandria UniversityAlexandriaEgypt
  5. 5.Department of Biology, Faculty of Science and Arts, BishaKing Khaled UniversityBishaSaudi Arabia

Personalised recommendations